Literature DB >> 12458033

Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors.

Michael S Exton1, Claudia Gierse, Bettina Meier, Martin Mosen, Yufen Xie, Stilla Frede, Marion U Goebel, Volker Limmroth, Manfred Schedlowski.   

Abstract

Using Cyclosporin A (CsA) as an unconditioned stimulus has previously demonstrated that behaviorally conditioned inhibition of splenocyte proliferation and cytokine production is mediated via the splenic nerve. Therefore, we currently examined the adrenergic modulation of conditioned suppression of splenocyte function. Chemical sympathectomy via 6-OHDA completely blocked the conditioned suppression of splenocyte proliferation to mitogens and cytokine (IL-2, IFN-gamma) production. Furthermore, administration of beta-adrenoceptor antagonist propranolol abrogated the conditioned effect on splenocyte proliferation. Supporting the position that conditioning is beta-adrenergic-dependent, addition of beta-adrenoceptor agonist, but not alpha-adrenoceptor agonists, to splenocytes in vitro mimicked the conditioned suppression of splenocyte functions, with these effects blocked by propranolol. Therefore, these data indicate that behavioral conditioning of splenocyte function in the rat is regulated by the sympathetic nervous system, predominantly via beta-adrenergic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458033     DOI: 10.1016/s0165-5728(02)00249-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  Behavioural conditioning as the mediator of placebo responses in the immune system.

Authors:  Sabine Vits; Elvir Cesko; Paul Enck; Uwe Hillen; Dirk Schadendorf; Manfred Schedlowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

Review 2.  The neuroscience of placebo effects: connecting context, learning and health.

Authors:  Tor D Wager; Lauren Y Atlas
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

Review 3.  Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy.

Authors:  Ángel Ortega; Juan Salazar; Néstor Galban; Milagros Rojas; Daniela Ariza; Mervin Chávez-Castillo; Manuel Nava; Manuel E Riaño-Garzón; Edgar Alexis Díaz-Camargo; Oscar Medina-Ortiz; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

4.  Surgical stress promotes tumor growth in ovarian carcinoma.

Authors:  Jeong-Won Lee; Mian M K Shahzad; Yvonne G Lin; Guillermo Armaiz-Pena; Lingegowda S Mangala; Hee-Dong Han; Hye-Sun Kim; Eun Ji Nam; Nicholas B Jennings; Jyotsnabaran Halder; Alpa M Nick; Rebecca L Stone; Chunhua Lu; Susan K Lutgendorf; Steve W Cole; Anna E Lokshin; Anil K Sood
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

Review 5.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

6.  Beta-adrenergic blockade blunts inflammatory and antiviral/antibody gene expression responses to acute psychosocial stress.

Authors:  Jennifer K MacCormack; Monica M Gaudier-Diaz; Emma L Armstrong-Carter; Jesusa M G Arevalo; Samantha Meltzer-Brody; Erica K Sloan; Steven W Cole; Keely A Muscatell
Journal:  Neuropsychopharmacology       Date:  2021-01-15       Impact factor: 7.853

7.  Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.

Authors:  Rosanne M Smits; Dieuwke S Veldhuijzen; Henriet van Middendorp; Petra C E Hissink Muller; Wineke Armbrust; Elizabeth Legger; Nico M Wulffraat; Andrea W M Evers
Journal:  Pediatr Rheumatol Online J       Date:  2020-02-07       Impact factor: 3.054

8.  Placebo effects on the immune response in humans: the role of learning and expectation.

Authors:  Antje Albring; Laura Wendt; Sven Benson; Oliver Witzke; Andreas Kribben; Harald Engler; Manfred Schedlowski
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.